We came across a bullish thesis on Twist Bioscience Corporation on Clinical Catalysts’s Substack. In this article, we will ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (TWST) (NASDAQ: TWST), a core mid-cap growth and value equity, in the life sciences segment of the health care sector, today ...

Twist Bioscience (NASDAQ:TWST) reported fiscal 2026 first-quarter results that management said extended a multi-year trend of consistent execution, highlighting its 12th consecutive quarter of revenue ...

Detailed price information for Twist Bioscience Corp (TWST-Q) from The Globe and Mail including charting and trades.

Twist Bioscience Corp (TWST) reports a 17% revenue increase, driven by AI-enabled discovery and strategic investments, while aiming for EBITDA breakeven by fiscal year-end.

Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced the publication in Science of the peer-reviewed paper, “Strengthening nucleic acid biosecurity ...

DNA Synthesis and Protein Solutions revenue increased to $51.1 million, a 27% year-over-year rise, with growth driven by AI-enabled discovery customers. NGS applications revenue was $52.6 million.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today ...